Alnylam Announces Pricing Of Upsized Offering Of $575 Mln Convertible Senior Notes Due 2028

(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced the pricing of its private offering of $575 million aggregate principal amount of 0.00% convertible senior notes due 2028. The size of the offering was increased from the previously announced offering of $500 million aggre https://www.nasdaq.com/articles/alnylam-announces-pricing-upsized-offering-575-mln-convertible-senior-notes-due-2028